Tranylcypromine hydrochlorideIrreversible inhibitor of MAO-A, MAO-B and LSD1 CAS# 1986-47-6 |
- PD 123319 ditrifluoroacetate
Catalog No.:BCC1841
CAS No.:136676-91-0
- Irbesartan
Catalog No.:BCC2560
CAS No.:138402-11-6
- Olmesartan
Catalog No.:BCC1819
CAS No.:144689-24-7
- AVE 0991
Catalog No.:BCC4032
CAS No.:304462-19-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1986-47-6 | SDF | Download SDF |
| PubChem ID | 6419961 | Appearance | Powder |
| Formula | C9H12ClN | M.Wt | 169.65 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | 2-PCPA;4548-34-9 | ||
| Solubility | Soluble to 100 mM in water and to 100 mM in DMSO | ||
| Chemical Name | (1S,2R)-2-phenylcyclopropan-1-amine;hydrochloride | ||
| SMILES | C1C(C1N)C2=CC=CC=C2.Cl | ||
| Standard InChIKey | ZPEFMSTTZXJOTM-RJUBDTSPSA-N | ||
| Standard InChI | InChI=1S/C9H11N.ClH/c10-9-6-8(9)7-4-2-1-3-5-7;/h1-5,8-9H,6,10H2;1H/t8-,9+;/m1./s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110) and monoamine oxidase (MAO). Inhibits histone demethylation. In combination with CHIR 99021, enables reprogramming of mouse embryonic fibroblasts transduced by only two factors, Oct4 and Klf4, into induced pluripotent stem (iPS) cells. |
Tranylcypromine hydrochloride Dilution Calculator
Tranylcypromine hydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.8945 mL | 29.4724 mL | 58.9449 mL | 117.8898 mL | 147.3622 mL |
| 5 mM | 1.1789 mL | 5.8945 mL | 11.789 mL | 23.578 mL | 29.4724 mL |
| 10 mM | 0.5894 mL | 2.9472 mL | 5.8945 mL | 11.789 mL | 14.7362 mL |
| 50 mM | 0.1179 mL | 0.5894 mL | 1.1789 mL | 2.3578 mL | 2.9472 mL |
| 100 mM | 0.0589 mL | 0.2947 mL | 0.5894 mL | 1.1789 mL | 1.4736 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Tranylcypromine, also known as 2-PCPA, is a monoamine oxidase inhibitor (MAOI) that irreversibly inhibits MAO A and MAO B with the inhibition constant Ki values of 101.9 μM and 16 μM and the half maximal inhibition concentration IC50 values of 2.3 μM and 0.95 μM respectively [1].
Tranylcypromine has also been found to potently and irreversibly inhibit histone demethylase lysine-specific demethylase 1 (LSD1), which is an amine oxidase homologue of MAO sharing similarities in the catalytic site with MAO A and B, in a time dependent and mechanism based manner with Ki and IC50 values of 242 μM and 20.7 μM respectively [1].
Reference
References:
[1] Schmidt DM, McCafferty DG. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry. 2007 Apr 10;46(14):4408-16. Epub 2007 Mar 17.
- Fmoc-Ser(tBu)-ol
Catalog No.:BCC2578
CAS No.:198561-87-4
- Fmoc-HoTyr-OH.DCHA
Catalog No.:BCC3246
CAS No.:198560-10-0
- Fmoc-Asparaginol(Trt)
Catalog No.:BCC3042
CAS No.:198543-08-7
- 9,10-Anthracenedione
Catalog No.:BCN3469
CAS No.:19852-76-7
- Bazedoxifene acetate
Catalog No.:BCC1412
CAS No.:198481-33-3
- Bazedoxifene
Catalog No.:BCC1411
CAS No.:198481-32-2
- Bazedoxifene HCl
Catalog No.:BCC4492
CAS No.:198480-56-7
- Boc-Pen(pMeBzl)-OH.DCHA
Catalog No.:BCC2623
CAS No.:198474-61-2
- Parecoxib Sodium
Catalog No.:BCC4248
CAS No.:198470-85-8
- Parecoxib
Catalog No.:BCC4041
CAS No.:198470-84-7
- Boc-D-Pen(pMeBzl)-OH.DCHA
Catalog No.:BCC3308
CAS No.:198470-36-9
- LY 367385
Catalog No.:BCC6983
CAS No.:198419-91-9
- Alisol A 23-acetate
Catalog No.:BCN3457
CAS No.:19865-75-9
- Alisol B acetate
Catalog No.:BCN2304
CAS No.:19865-76-0
- Cabralealactone
Catalog No.:BCN4870
CAS No.:19865-87-3
- MLCK inhibitor peptide
Catalog No.:BCC5852
CAS No.:198694-74-5
- 1,3-Dicaffeoylquinic acid
Catalog No.:BCN2972
CAS No.:19870-46-3
- Bavachinin
Catalog No.:BCN4871
CAS No.:19879-30-2
- Bavachin
Catalog No.:BCN4872
CAS No.:19879-32-4
- Windorphen
Catalog No.:BCC6486
CAS No.:19881-70-0
- Merimepodib
Catalog No.:BCC4128
CAS No.:198821-22-6
- (7R)-Methoxy-8-epi-matairesinol
Catalog No.:BCN7582
CAS No.:198827-23-5
- Z-D-Tyr(tBu)-OH.DCHA
Catalog No.:BCC2744
CAS No.:198828-72-7
- H-D-Phg-OMe.HCl
Catalog No.:BCC3314
CAS No.:19883-41-1
Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.[Pubmed:19839055]
Stem Cells. 2009 Dec;27(12):2992-3000.
Induced pluripotent stem cell technology has attracted enormous interest for potential application in regenerative medicine. Here, we report that a specific glycogen synthase kinase 3 (GSK-3) inhibitor, CHIR99021, can induce the reprogramming of mouse embryonic fibroblasts transduced by only two factors, Oct4 and Klf4. When combined with Parnate (also named tranylcypromine), an inhibitor of lysine-specific demethylase 1, CHIR99021 can cause the reprogramming of human primary keratinocyte transduced with the two factors, Oct4 and Klf4. To our knowledge, this is the first time that human iPS cells have been generated from somatic cells without exogenous Sox2 expression. Our studies suggest that the GSK-3 inhibitor might have a general application to replace transcription factors in both mouse and human reprogramming.
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.[Pubmed:17367163]
Biochemistry. 2007 Apr 10;46(14):4408-16.
The catalytic domain of the flavin-dependent human histone demethylase lysine-specific demethylase 1 (LSD1) belongs to the family of amine oxidases including polyamine oxidase and monoamine oxidase (MAO). We previously assessed monoamine oxidase inhibitors (MAOIs) for their ability to inhibit the reaction catalyzed by LSD1 [Lee, M. G., et al. (2006) Chem. Biol. 13, 563-567], demonstrating that trans-2-phenylcyclopropylamine (2-PCPA, tranylcypromine, Parnate) was the most potent with respect to LSD1. Here we show that 2-PCPA is a time-dependent, mechanism-based irreversible inhibitor of LSD1 with a KI of 242 microM and a kinact of 0.0106 s-1. 2-PCPA shows limited selectivity for human MAOs versus LSD1, with kinact/KI values only 16-fold and 2.4-fold higher for MAO B and MAO A, respectively. Profiles of LSD1 activity and inactivation by 2-PCPA as a function of pH are consistent with a mechanism of inactivation dependent upon enzyme catalysis. Mass spectrometry supports a role for FAD as the site of covalent modification by 2-PCPA. These results will provide a foundation for the design of cyclopropylamine-based inhibitors that are selective for LSD1 to probe its role in vivo.
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.[Pubmed:16793513]
Chem Biol. 2006 Jun;13(6):563-7.
Demethylation of histone H3 lysine 4 is carried out by BHC110/LSD1, an enzyme with close homology to monoamine oxidases (MAO). Monoamine oxidase A or B are frequent targets of selective and nonselective small molecular inhibitors used for treatment of depression. Here we show that in contrast to selective monoamine oxidase inhibitors such as pargyline, nonselective monoamine oxidase inhibitors potently inhibit nucleosomal demethylation of histone H3 lysine 4. Tranylcypromine (brand name Parnate) displayed the best inhibitory activity with an IC50 of less than 2 microM. Treatment of P19 embryonal carcinoma cells with tranylcypromine resulted in global increase in H3K4 methylation as well as transcriptional derepression of two BHC110 target genes, Egr1 and the pluripotent stem cell marker Oct4. These results attest to the effectiveness of tranylcypromine as a small molecular inhibitor of histone demethylation.
